Suppr超能文献

一种用于治疗心力衰竭的特定强心苷和另一种用于治疗心房颤动的强心苷?

A specific cardiac glycoside for cardiac failure and another for atrial fibrillation?

作者信息

Joubert P, van der Meer L

出版信息

S Afr Med J. 1979 Dec 8;56(24):1040-2.

PMID:550438
Abstract

Ouabain produces a greater degree of prolongation of the P-R interval than digitoxin in rats when dosages which produce similar inotropic responses are used. When digitoxin is administered after pretreatment with propranolol, it produces prolongation of the P-R interval comparable to that produced by ouabain. Indications in the literature that these findings may apply to human beings suggest that in some situations atrial fibrillation may be better controlled with a hydrophilic digitalis preparation (e.g. ouabain), whereas cardiac failure with a tendency to atrioventricular block may be better controlled with a lipophilic preparation (e.g. digitoxin).

摘要

当使用产生相似变力性反应的剂量时,哇巴因比地高辛能使大鼠的P-R间期延长程度更大。在用普萘洛尔预处理后给予地高辛,它所产生的P-R间期延长与哇巴因相当。文献中的迹象表明这些发现可能适用于人类,这提示在某些情况下,心房颤动可能用亲水性洋地黄制剂(如哇巴因)能得到更好的控制,而伴有房室传导阻滞倾向的心力衰竭可能用亲脂性制剂(如地高辛)能得到更好的控制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验